Centrus Energy Stock Crashes 26%: Is the Nuclear Fuel Leader a Buy?

Centrus Energy (LEU) stock plummeted 26% in October, according to S&P Global Market Intelligence, while the S&P 500 dipped just 0.5%. This sharp decline followed a disappointing September, when shares fell 18.6%. The sell-off was triggered by the company's announcement on October 19 that it would acquire Westerman Holdings, one of its largest suppliers, for approximately $95 million in cash and $21 million in equity.

Investors reacted negatively to the deal, sending shares down more than 4% on the day of the announcement. The acquisition is intended to build supply chain resilience and diversify revenue beyond nuclear into oil and gas and other industrial sectors. However, analysts were quick to express skepticism. On October 20, Roth Capital slashed its price target to $115 from $188, maintaining a neutral rating, and warned that third-quarter results could disappoint.

Other major firms followed suit: Barclays lowered its target to $150 from $207 on October 20, UBS cut it to $120 from $185 on October 23, and JPMorgan reduced its target to $120 from $180 on October 26. These downward revisions reflected concerns about the acquisition's impact on near-term financials and the company's strategic direction.

Centrus is a leading provider of nuclear fuel and services, and it is uniquely positioned in the production of high-assay low-enriched uranium (HALEU), a specialized fuel required by small modular reactors (SMRs). As of the end of September 2026, the company reported a backlog of $5.4 billion across its low-enriched uranium (LEU) and HALEU businesses, underscoring its strong long-term demand.

The steep decline in October has left investors wondering whether the stock is now a bargain or a value trap. While analysts have turned bearish, the company's fundamental strengths and the growing nuclear energy renaissance suggest that the sell-off may be overdone.

The market's harsh reaction to the Westerman acquisition highlights a classic tension: investors often punish companies for diversifying away from their core business, especially when the deal involves a supplier. By acquiring Westerman, Centrus aims to control more of its supply chain and reduce reliance on third parties, which could improve margins and operational stability in the long run. However, the upfront costs and integration risks have raised doubts about near-term earnings.

Analyst downgrades carry significant weight, as they influence institutional and retail sentiment. The coordinated cuts from Roth Capital, Barclays, UBS, and JPMorgan signal that Wall Street sees limited upside in the near term. This can create downward pressure on the stock as funds adjust their positions. However, it's important to note that price targets are often revised reactively, and the market may have overreacted.

Centrus's competitive advantage in HALEU production is a critical differentiator. As the world transitions to cleaner energy, small modular reactors are expected to play a major role, and Centrus is one of the few companies capable of producing the fuel they need. The $5.4 billion backlog provides strong revenue visibility and demonstrates that demand for its products remains robust.

For long-term investors, the recent dip could represent an attractive entry point. The nuclear energy sector is gaining momentum globally, driven by decarbonization goals and energy security concerns. Centrus, with its unique technology and strategic position, is well-placed to capitalize on this trend. The acquisition of Westerman, while initially unpopular, may ultimately strengthen the company's supply chain and diversify its revenue streams.

Short-term volatility is likely to persist as the market digests the acquisition and awaits third-quarter results. However, the underlying fundamentals of the nuclear fuel market remain strong, and Centrus's leadership in HALEU positions it for significant growth in the coming years.